Disc Medicine drops after stock offering priced
Brief: Disc Medicine Announces Pricing Of $225.5 Mln Upsized Public Offering Of Common Stock And Pre-Funded Warrants
U.S. STOCKS ON THE MOVE-SmartFinancial, TE Connectivity, Arista Networks
U.S. STOCKS ON THE MOVE-MP Materials, Seagate, Teledyne
U.S. STOCKS ON THE MOVE-Interactive Brokers, Travelers, LanzaTech
Disc Medicine slips on planned stock sale
Disc Medicine falls after flagging 'material weakness'
Brief: Disc Medicine Expects To Report Material Weakness in Annual Report
Brief: Disc Medicine Presents Positive Updated Results From Phase 1B Trial In Patients With Myelofibrosis (MF) And Anemia
Brief: Disc Medicine Secures $200 Million In Non-Dilutive Debt Financing From Hercules Capital
U.S. RESEARCH ROUNDUP-Cigna, Marriott, Ralph Lauren
U.S. STOCKS ON THE MOVE-Disc Medicine, Peloton, Sherwin-Williams
Disc Medicine surges on positive FDA feedback for genetic disorder drug
Brief: Disc Medicine Announces Successful End Of Phase 2 Meeting With FDA For Bitopertin In Erythropoietic Protoporphyria
Brief: Disc Medicine Presents Positive Data From SAD Cohorts Of A Phase 1B Trial In Patients With Chronic Kidney Disease & Anemia At ASN Kidney Week
Brief: Disc Medicine Appoints Seasoned Industry Executive Rahul Kaushik, Ph.D. As Chief Technical Officer
Brief: Disc Medicine Appoints Industry Veteran Steve Caffé, MD As Chief Regulatory Officer
Disc Medicine Inc reports results for the quarter ended in June - Earnings Summary
U.S. RESEARCH ROUNDUP-Duolingo, Nova, Universal Health Services